IP Library Granted Patent US 11,083,689
Granted Patent B2
US 11,083,689 · App. 16/671,707 · Granted Aug 10, 2021

Lubricant formulations

Inventors: Kurt Richards (Herriman, UT); Andrew Hoover (Pleasant Grove, UT)
Assignee: REOXCYN, LLC
A61K9/0034A61K8/0216A61K8/20A61K8/24A61K8/25A61K8/891A61K33/20A61K47/02A61K47/34A61L31/14A61L31/16A61Q17/005A61Q19/00A61L2300/404A61L2400/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,083,689
App. No.
16/671,707
Granted
Aug 10, 2021
Kind
B2
Abstract

A composition for lubricant formulations is disclosed. The composition may include hypochlorite, dimethicone, and an emulsifier for improvement of lubricity. Methods of making and using the lubricant formulations are also disclosed.

Claims (22)

1. A medical lubricant, comprising:

hypochlorite;

an emulsifier comprising sodium magnesium silicate;

a silicone polymer; and

a buffer.

2. The medical lubricant of claim 1 , wherein the hypochlorite is present in an amount of about 50 to about 100 ppm.

3. The medical lubricant of claim 2 , wherein the hypochlorite is present in an amount of about 75 ppm.

4. The medical lubricant of claim 1 , wherein the buffer is sodium phosphate.

5. The medical lubricant of claim 1 , wherein the emulsifier is present in an amount of about 0.05%, 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 6%, 7%, 10%, or 15% w/v.

6. The medical lubricant of claim 5 , wherein the emulsifier is present in an amount of about 0.2% w/v.

7. The medical lubricant of claim 1 , wherein the silicone polymer is dimethicone.

8. The medical lubricant of claim 1 , wherein the silicone polymer is present in an amount of about 0.5%, 1%, 5%, 10%, 15%, 20%, 30%, 40%, or 50% w/v.

9. The medical lubricant of claim 8 , wherein the silicone polymer is present in an amount of about 10% w/v.

10. The medical lubricant of claim 1 , further comprising water.

11. The medical lubricant of claim 1 , wherein the sodium magnesium silicate is present in an amount of about 0.1%, 0.25%, 0.5%, 0.75%, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 6%, 7%, 10%, or 15% w/v.

12. The medical lubricant of claim 11 , wherein the sodium magnesium silicate is present in an amount of about 3.25% w/v.

13. The medical lubricant of claim 1 , wherein the lubricant has an osmolality of about 10, 15, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 65, 70, 80, 90, or 100 mOsm/kg, as measured by freezing point osmometry.

14. The medical lubricant of claim 13 , wherein the lubricant has an osmolality of about 22 mOsm/kg, as measured by freezing point osmometry.

15. The medical lubricant of claim 13 , wherein the lubricant has an osmolality of about 54 mOsm/kg, as measured by freezing point osmometry.

16. A method for facilitating insertion of a medical device into a subject, comprising applying the medical lubricant of claim 1 to a medical device.

17. The medical lubricant of claim 1 , wherein the hypochlorite is in an amount of about 75 ppm, wherein the silicone polymer comprises dimethicone in an amount of about 10% w/v, wherein the sodium phosphate in an amount of about 0.2% w/v, and wherein the lubricant further comprises sodium magnesium silicate in an amount of about 3.25% w/v, and water in an amount of about 61.55% w/v.

18. A method for facilitating insertion of a medical device into a subject, comprising applying the medical lubricant of claim 17 to a medical device.

Continuity (4)
Continuation 15818531 · Nov 20, 2017
Division 15266147 · Sep 15, 2016
Continuation 15158442 · May 18, 2016
Related Publication 20200237655A1 · Jul 30, 2020